Guest Post by Alex Berenson
A Centers for Disease Control report links Pfizer’s bivalent booster to strokes. The news follows several other recent findings of concern. But don’t worry! The Washington Post says everything’s fine.
Pfizer’s bivalent Covid booster raised the risk of stroke for people over 65, according to a federal database that the government considers the gold standard for tracking vaccine side effects.
The Centers for Disease Control said Friday afternoon it had received 130 reports of ischemic stroke in people over 65 who had received the new Pfizer jab less than three weeks before. An ischemic stroke occurs when a blood clot blocks the flow of oxygen to the brain.
The CDC and vaccine advocates in the media immediately downplayed the potential importance of the finding. But it is only the latest to suggest the mRNA shots have serious cardiovascular risks that may increase with repeated dosing.
The stroke finding follows a report last month from Food & Drug Administration researchers that an earlier version of Pfizer shot was associated with pulmonary embolisms in a different database. Notably, the FDA database initially revealed a broader range of potential cardiac problems, including heart attacks. (Interestingly, both findings suggest the Pfizer mRNA jab carries more clotting risk than Moderna’s version.)
Independent researchers are also now finding new evidence for the mechanism by which the shots cause myocarditis, or heart inflammation – a now-proven link.
